Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
l-carnitine + selenium is a combination of two well-known antioxidant compounds often formulated together as a dietary supplement or medical food, particularly used in populations with increased oxidative stress such as phenylketonuria (PKU), osteoarthritis, thyroid diseases, and potentially other conditions involving oxidative imbalance. - **l-carnitine** acts primarily as a transporter of long-chain fatty acids into mitochondria for energy production and possesses direct antioxidant effects. - **selenium** is an essential trace mineral that serves as a cofactor for several antioxidant enzymes, notably glutathione peroxidase, which helps detoxify harmful peroxides in cells. Joint supplementation of l-carnitine and selenium has been shown to restore antioxidant capacity, reduce lipid and protein oxidative damage, and improve enzymatic antioxidant defense (such as glutathione peroxidase activity) in conditions associated with oxidative stress, e.g., PKU and thyroid dysfunction[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on l-carnitine + selenium.